April 28th 2025
Limiting the number of fresh donor oocytes fertilized can reduce excess embryo creation while maintaining high live birth rates.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Out-of-pocket infertility costs vary widely
January 1st 2014Out-of-pocket costs for couples being treated for infertility range from a low of $912 for medication only to $19,234 for in vitro fertilization (IVF), according to researchers who say their data will help couples plan for the expenses they may incur. The current study is published online in the Journal of Urology ahead of the February 2014 print issue.
Read More
Multiple births 20 times more expensive than singletons
November 27th 2013A retrospective analysis of more than 400,000 U.S. births over nearly 6 years shows that delivery of triplets or more costs 20 times as much as a singleton. Published in The American Journal of Obstetrics and Gynecology, the report may be the first to look at medical expenses for both maternal and infant care associated with IVF-assisted pregnancy.
Read More
Endocrine Society releases PCOS guidelines
October 31st 2013The Endocrine Society's new clinical practice guideline on polycystic ovary syndrome (PCOS) recommends diagnosis based on two of three key features of he condition. The advice, published in the Journal of Clinical Endocrinology and Metabolism, is aimed at reducing the need for ultrasound or hormone tests in patient evaluation.
Read More
Investigational fertility treatment approved by FDA
September 12th 2013The US Food and Drug Administration approved the new drug application (NDA) for Merck’s investigational fertility treatment corifollitropin alfa. Merck is seeking approval for the use of corifollitropin alfa in controlled ovarian stimulation (COS). If approved, the drug would be the first sustained follicular stimulant available in the United States.
Read More
Health Disparities in Uterine Fibroid Patients: a Q&A
September 9th 2013The findings of a recent study have shown that uterine fibroid tumors are more common and more severe in African American women compared with white women. Find out how you can better treat uterine fibroid tumors in this high-risk population.
Read More
Mobile healthcare apps and devices are expected to grow at a rate of 61% a year, with 50% of healthcare professionals using at least one app. Ob/gyns are leading the charge, and these 8 apps are helping MDs and HCPs manage patients and stay current on everything happening in the field.
Read More
Which Contraceptive Is Best for Women With Diabetes Mellitus?
May 15th 2013There is insufficient evidence to determine that hormonal contraceptives do not influence glucose and lipid metabolism in women with diabetes mellitus, concluded a systematic review conducted by the Cochrane Fertility Regulation Group.
Read More